200
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Impact of free curcumin and curcumin nanocapsules on viability and oxidative status of neural cell lines

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 155-165 | Received 29 Jun 2021, Accepted 29 Nov 2021, Published online: 20 Dec 2021

References

  • Ahmed, K., et al., 2012. Nanoemulsion- and emulsion-based delivery systems for curcumin: encapsulation and release properties. Food Chemistry, 132 (2), 799–807.
  • Ahn, S., Costa, J., and Emanuel, J., 1996. PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR. Nucleic Acids Research, 24 (13), 2623–2625.
  • Armağan, H.H. and Nazıroğlu, M., 2021. Curcumin attenuates hypoxia-induced oxidative neurotoxicity, apoptosis, calcium, and zinc ion influxes in a neuronal cell line: involvement of TRPM2 channel. Neurotoxicity Research, 39 (3), 618–633.
  • Ayati, Z., et al., 2019. Ethnobotany, phytochemistry and traditional uses of Curcuma spp. and pharmacological profile of two important species (C. longa and C. zedoaria): a review. Current Pharmaceutical Design, 25 (8), 871–935.
  • Azami, S.J., et al., 2018. Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice. International Journal of Nanomedicine, 13, 7363–7374.
  • Bagheri, H., et al., 2020. Effects of curcumin on mitochondria in neurodegenerative diseases. BioFactors, 46 (1), 5–20.
  • Bala, K., Tripathy, B.C., and Sharma, D., 2006. Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions. Biogerontology, 7 (2), 81–89.
  • Balaji, S. and Chempakam, B., 2010. Toxicity prediction of compounds from turmeric (Curcuma longa L). Food and Chemical Toxicology, 48 (10), 2951–2959.
  • Barzegar, A. and Moosavi-Movahedi, A.A., 2011. Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. PLoS One, 6 (10), e26012.
  • Bhat, A., et al., 2019. Benefits of curcumin in brain disorders. BioFactors, 45 (5), 666–689.
  • Camacho-Barquero, L., et al., 2007. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. International Immunopharmacology, 7 (3), 333–342.
  • Choi, W., et al., 2012. The regulatory effect of veratric acid on NO production in LPS-stimulated RAW264.7 macrophage cells. Cellular Immunology, 280 (2), 164–170.
  • Copetti, P.M., et al., 2020. Development, characterisation, stability study and antileukemic evaluation of nanoemulsions containing Astrocaryum aculeatum extract. Natural Product Research, 1–6.
  • Costa, F., et al., 2012. Influence of Val16Ala SOD2 polymorphism on the in-vitro effect of clomiphene citrate in oxidative metabolism. Reproductive Biomedicine Online, 24 (4), 474–481.
  • da Costa, I.M., et al., 2019. Supplementation with Curcuma longa reverses neurotoxic and behavioral damage in models of Alzheimer’s disease: a systematic review. Current Neuropharmacology, 17 (5), 406–421.
  • Dalcin, A.J.F., et al., 2019. Nanoencapsulation of the flavonoid dihydromyricetin protects against the genotoxicity and cytotoxicity induced by cationic nanocapsules. Colloids and Surfaces. B, Biointerfaces, 173, 798–805.
  • Del Prado-Audelo, M.L., et al., 2019. Formulations of curcumin nanoparticles for brain diseases. Biomolecules, 9 (2), 56–28.
  • Eisenbrand, G., et al., 2002. Methods of in vitro toxicology. Food and Chemical Toxicology, 40 (2–3), 193–236.
  • Fan, C., et al., 2018. Neuroprotective effects of curcumin on IL-1β-induced neuronal apoptosis and depression-like behaviors caused by chronic stress in rats. Frontiers in Cellular Neuroscience, 12, 516–517.
  • Fujisawa, S., et al., 2004. Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. Anticancer Research, 24 (2B), 563–569.
  • Fukui, M., Choi, H.J., and Zhu, B.T., 2010. Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radical Biology & Medicine, 49 (5), 800–813.
  • Gartlon, J., et al., 2006. Evaluation of a proposed in vitro test strategy using neuronal and non-neuronal cell systems for detecting neurotoxicity. Toxicology in Vitro, 20 (8), 1569–1581.
  • Ghasemi, F., et al., 2019. Effects of curcumin on microglial cells. Neurotoxicity Research, 36 (1), 12–26.
  • Gündel, S., et al., 2019. Evaluation of cytotoxicity, genotoxicity and ecotoxicity of nanoemulsions containing Mancozeb and Eugenol. Ecotoxicology and Environmental Safety, 169, 207–215.
  • Gündel, S.S., et al., 2018. Basil oil-nanoemulsions: development, cytotoxicity and evaluation of antioxidant and antimicrobial potential. Journal of Drug Delivery Science and Technology, 46, 378–383.
  • Hewlings, S. and Kalman, D., 2017. Curcumin: a review of its effects on human health. Foods, 6 (10), 92.
  • Jaguezeski, A.M., et al., 2019. Low-dose curcumin-loaded Eudragit L-100-nanocapsules in the diet of dairy sheep increases antioxidant levels and reduces lipid peroxidation in milk. Journal of Food Biochemistry, 43 (8), 1–14.
  • Khan, M.S., et al., 2019. Dietary supplementation of the antioxidant curcumin halts systemic LPS-induced neuroinflammation-associated neurodegeneration and memory/synaptic impairment via the JNK/NF-κB/Akt signaling pathway in adult rats. Oxidative Medicine and Cellular Longevity, 2019, 1–23.
  • Khazdair, M.R., et al., 2019. Neuroprotective potency of some spice herbs, a literature review. Journal of Traditional and Complementary Medicine, 9 (2), 98–105.
  • Kunwar, A., et al., 2008. Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. Biochimica et Biophysica Acta, 1780 (4), 673–679.
  • Liczbiński, P., Michałowicz, J., and Bukowska, B., 2020. Molecular mechanism of curcumin action in signaling pathways: review of the latest research. Phytotherapy Research, 34 (8), 1992–2005.
  • Maiti, P. and Dunbar, G., 2018. Use of curcumin, a natural polyphenol for targeting molecular pathways in treating age-related neurodegenerative diseases. International Journal of Molecular Sciences, 19 (6), 1637.
  • Mendonça, L.M., et al., 2009. Evaluation of the cytotoxicity and genotoxicity of curcumin in PC12 cells. Mutation Research, 675 (1–2), 29–34.
  • Mursaleen, L., Somavarapu, S., and Zariwala, M.G., 2020. Deferoxamine and curcumin loaded nanocarriers protect against rotenone-induced neurotoxicity. Journal of Parkinson’s Disease, 10 (1), 99–111.
  • Nakamae, I., et al., 2019. Curcumin derivatives verify the essentiality of ROS upregulation in tumor suppression. Molecules, 24 (22), 4067–4025.
  • Namgyal, D., et al., 2020. The neuroprotective effect of curcumin against Cd-induced neurotoxicity and hippocampal neurogenesis promotion through CREB-BDNF signaling pathway. Toxicology, 442, 152542.
  • Parasuraman, S., 2011. Toxicological screening. Journal of Pharmacology & Pharmacotherapeutics, 2 (2), 74–79.
  • Qureshi, S., Shah, A.H., and Ageel, A.M., 1992. Toxicity studies on Alpinia galanga and Curcuma longa. Planta Medica, 58 (2), 124–127.
  • Rakotoarisoa, M. and Angelova, A., 2018. Amphiphilic nanocarrier systems for curcumin delivery in neurodegenerative disorders. Medicines, 5 (4), 126.
  • Sadegh Malvajerd, S., et al., 2019. Brain delivery of curcumin using solid lipid nanoparticles and nanostructured lipid carriers: preparation, optimization, and pharmacokinetic evaluation. ACS Chemical Neuroscience, 10 (1), 728–739.
  • Soleimani, V., Sahebkar, A., and Hosseinzadeh, H., 2018. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: review. Phytotherapy Research, 32 (6), 985–995.
  • Syng-Ai, C., Kumari, A.L., and Khar, A., 2004. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Molecular Cancer Therapeutics, 3 (9), 1101–1108.
  • Tomeh, M.A., Hadianamrei, R., and Zhao, X., 2019. A review of curcumin and its derivatives as anticancer agents. International Journal of Molecular Sciences, 20 (5), 1033.
  • Umerska, A., et al., 2018. Polymeric nanoparticles for increasing oral bioavailability of Curcumin. Antioxidants, 7 (4), 46.
  • Vaiserman, A., Koliada, A., and Lushchak, O., 2020. Neuroinflammation in pathogenesis of Alzheimer’s disease: phytochemicals as potential therapeutics. Mechanisms of Ageing and Development, 189, 111259.
  • Wang, Z., et al., 2020. A curcumin derivative activates TFEB and protects against parkinsonian neurotoxicity in vitro. International Journal of Molecular Sciences, 21 (4), 1515.
  • Wei, W., et al., 2021. Dichloroacetic acid-induced dysfunction in rat hippocampus and the protective effect of curcumin. Metabolic Brain Disease, 36 (4), 545–556.
  • Willenbacher, E., et al., 2019. Curcumin: new insights into an ancient ingredient against cancer. International Journal of Molecular Sciences, 20 (8), 1808–1813.
  • Xiang, B., et al., 2021. Curcumin ameliorates copper-induced neurotoxicity through inhibiting oxidative stress and mitochondrial apoptosis in SH-SY5Y cells. Neurochemical Research, 46 (2), 367–378.
  • Zaki, S.M., et al., 2020. Nano-curcumin versus curcumin in amelioration of deltamethrin-induced hippocampal damage. Histochemistry and Cell Biology, 154 (2), 157–175.
  • Zhang, J., et al., 2019. Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/ TLR4/ NF-κB pathways in BV2 cells. Molecular Immunology, 116, 29–37.
  • Zielińska, A., et al., 2020. Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules, 25 (16), 3731.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.